Overview
The fund invests in equities of major Swiss companies listed in the SPI 20®.
No investments in securities on the recommendation list for the exclusion of SVVK-ASIR (www.svvk-asir.ch) and controversial weapons.
Portfolio is passively managed and aims to replicate the gross performance of the benchmark (before fees).
The investment objective is to generate a performance in line with that of the benchmark, keeping the Tracking Error below the maximum of 0.3% over a rolling period of 3 years.
Benefits
Easy access to the Swiss stock market.
Optimised risk/return profile thanks to a broad diversification across a range of sectors.
Provides access to the performance of the index with a single transaction.
The fund is transparent and cost-effective and is liquid under normal market conditions.
You do not pay any federal stamp duty.
Risks
Features
| Product category |
麻豆社 Equity Funds 麻豆社 Index Funds Equities |
| Product domicile |
Switzerland
|
| Portfolio management |
麻豆社 Asset Management Switzerland AG, Zurich
|
| Fund management |
麻豆社 Fund Management (Switzerland) AG
|
| Custodian bank |
麻豆社 Switzerland AG, Zurich
|
| Day of inception |
February 27, 2017
|
| Currency of account |
CHF
|
| Close of financial year |
September 30
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.14% p.a.
|
| Management fee |
0.10% p.a.
|
| Total expense ratio (TER) |
0.14% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
SPI 20 (Total Return)
|
| Securities no. |
35656940
|
| ISIN |
CH0356569407
|
| Bloomberg Ticker |
UIESPWC SW
|
Performance and Prices
Percentage growth
as of May 27, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 5.66 | 7.47 | 6.39 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 17.84 | 18.85 | 34.80 |
| 3Y | |||
| 5Y | 36.01 | 62.87 | 55.19 |
| ø p.a.5Y | 6.34 | 10.25 | 9.19 |
Current data
| Net asset value | 27.05.2026 | CHF 193.84 |
| High - last 12 months | 27.05.2026 | CHF 193.84 |
| Low - last 12 months | 06.08.2025 | CHF 163.89 |
| Assets of the unit class in mn | 27.05.2026 | CHF 22.00 |
| Total product assets in mn | 27.05.2026 | CHF 991.80 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 30.04.2026 | 12.63% | 12.62% |
| Sharpe Ratio | 30.04.2026 | 0.84 | 0.45 |
| Risk Free Rate | 30.04.2026 | 0.40% | 0.41% |
Structures
By the 10 largest positions (in %, as of April 30, 2026)
|
|
|
| Novartis AG | 16.77 |
| Roche Holding AG | 16.48 |
| Nestle SA | 15.01 |
| ABB Ltd | 9.12 |
| 麻豆社 Group AG | 7.80 |
| Zurich Insurance Group AG | 6.15 |
| Cie Financiere Richemont SA | 5.88 |
| Holcim AG | 2.85 |
| Swiss Re AG | 2.77 |
| Lonza Group AG | 2.48 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
||
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|
|
Document type
|
Document Language
|
|||
| Tax list |
|
|
|
|